Anders Groenlund

All articles written by: Anders Groenlund 

Author: Anders Groenlund
Head of Regulatory Affairs
EFSA has found no health concerns from altering the maximum residue levels (MRLs) of the herbicide glyphosate in certain crops, reaffirming its earlier conclusions that glyphosate is unlikely to pose a risk when used as currently authorized.
Amid rising concerns about animal welfare, a closer look at how fetal bovine serum (FBS) is sourced reveals a reality grounded in veterinary ethics and scientific necessity. Contrary to some misconceptions, the collection of FBS follows strict animal welfare standards and supports vital advances in cell therapy, vaccine development, and biomedical research.
From the moment a pregnant bovine is slaughtered to the final bottling of fetal bovine serum (FBS), a complex, ethically governed supply chain supports life-saving research worldwide—ensuring both transparency and quality in a field under growing scrutiny.
Fetal Bovine Serum (FBS) is a critical raw material in biopharmaceutical research and production. This article explores its global supply chain, ethical sourcing, quality challenges, and its role as a standardized commodity in the life sciences industry.
Fetal Bovine Serum (FBS) plays a vital role in cell culture, but its use raises ethical and scientific challenges. This article explores how sourcing, safety, and alternatives impact the future of FBS in biomedical research and production.
The European Commission has approved a new regulation allowing the controlled re-entry of animal serum into the EU from select countries. This marks a critical turning point for researchers and manufacturers relying on FBS and other serum products.
Cookie Consent with Real Cookie Banner